会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明公开
    • Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors
    • Neue 17-β-羟基苯甲酰基-4-氮杂-5-α-雄甾-1-烯-3-酮的抑制睾丸素 - 放线菌素。
    • EP0462661A2
    • 1991-12-27
    • EP91201488.3
    • 1991-06-14
    • MERCK & CO. INC.
    • Steinberg, Nathan G.Rasmusson, Gary H.Salzmann, Thomas N.
    • C07J73/00A61K31/56
    • C07J73/005
    • Novel 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors of the formula:

      wherein

      R is selected from hydrogen, methyl and ethyl and
      R² is phenyl substituted with one or more of: -OH, -OC₁-C₄ alkyl, C₁-C₄ alkyl, -(CH₂) m H, -(CH₂) n COOR, including protected -OH, where m is 1-4, n is 1-3, and providing C₁-C₄ alkyl is only present when one of the above oxygen containing radicals is present, wherein the dotted line represents a double bond which can be present, pharmaceutically acceptable salts and esters thereof, and a pharmaceutical formulation thereof. The above compounds are active as testosterone reductase inhibitors and thus are useful topically for treatment of acne, seborrhea, female hirsutism, and systemically in treatment of benign prostatic hypertrophy.
    • 新型17β-羟基苯甲酰基-4-氮杂-5α-雄甾-1-烯-3-酮作为下式的睾酮还原酶抑制剂:其中R选自氢,甲基和乙基,R 2是苯基 被取代为-OH,-OC1-C4烷基,C1-C4烷基, - (CH2)mH, - (CH2)n COOR,包括被保护的-OH,其中m为1-4,n为1- 3,提供C1-C4烷基仅在存在上述含氧基团之一时存在,其中虚线表示可存在的双键,其药学上可接受的盐和酯及其药物制剂。 上述化合物作为睾酮还原酶抑制剂是有活性的,因此可用于治疗痤疮,脂溢性皮炎,女性多毛症,并且全身治疗良性前列腺肥大。 H
    • 24. 发明公开
    • Topical pharmaceutical composition containing 17-beta-methoxycarbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one
    • Topisches Arzneimittel enthaltend 17-β-甲氧羰基-4-甲基-4-氮杂-5-α-雄甾-1-烯-3-酮。
    • EP0271219A1
    • 1988-06-15
    • EP87309949.3
    • 1987-11-11
    • Merck & Co., Inc.
    • Rasmusson, Gary H.Reynolds, Glenn F.
    • C07J73/00A61K31/435A61K31/58
    • C07J73/005C07C2603/16
    • 17β-Acyl-4-aza-5α-androst-1-en-3-ones of the formula:
      wherein R is selected from hydrogen, methyl and ethyl R² is methoxy, a monovalent radical selected from straight and branched chain alkyl of from 1-12 carbons, or monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or 1 or more halo (Cl or Br) substituents, aralkyl selected from benzyl and phenethyl and heterocyclic selected from 2- or 4-pyridyl, 2-pyrrolyl, 2-furyl or thiophenyl; and Rʹ, Rʹʹ and Rʹʹʹ are each selected from hydrogen and methyl and pharmaceutical formulations of the above compounds are active as testosterone 5α-reductase inhibitors and thus are useful for treatment of acne, seborrhea, female hirsutism, and benign prostatic hypertrophy.
    • 17β-乙酰基-4-氮杂-5α-雄甾-1-烯-3-酮,其具有下式:其中R选自氢,甲基和乙基,R 2为甲氧基,一价基团选自 1-12个碳原子的直链和支链烷基,或任选含有1个或多个1-2个碳原子的低级烷基取代基和/或1个或更多个卤代(Cl或Br)取代基的芳环,或选自苄基和苯乙基 和杂环选自2-或4-吡啶基,2-吡咯基,2-呋喃基或噻吩基; 和R',R“和R”'各自选自氢和甲基,并且上述化合物的药物制剂作为睾酮5α-还原酶抑制剂是有活性的,因此可用于治疗痤疮,皮脂溢,雌性多毛症和 良性前列腺肥大。